This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
National Peroxide board to consider revised audited FY26 results on Aug 12
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.7 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited has informed BSE that its Board of Directors will meet on August 12, 2026 to consider and approve revised audited financial results and statements for Q4 and FY ended March 31, 2026, along with unaudited financial results for Q1 ended June 30, 2026. The use of the word 'revised' indicates the earlier audited figures are being restated rather than simply re-confirmed. No financial numbers are provided in this intimation.
Revised audited numbers suggest a restatement of earlier filed results; investors should watch for material changes when the revised figures are disclosed on Aug 12.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹96.07 Cr | ₹66.66 Cr | +44.1% |
| Operating profit | ₹6.71 Cr | −₹0.67 Cr | turned positive |
| Profit after tax | ₹6.61 Cr | ₹0.89 Cr | +642.3% |
| EBITDA margin | 12.7% | 7.2% | +5.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.